- Home
- RVTY
RVTY
Revvity Inc.
as 11-25-2025 3:37pm EST
Revvity provides instruments, tests, services, and software solutions to the pharmaceutical, biomedical, chemical, environmental, and general industrial markets. The company operates in two segments. First, its diagnostics segment includes immunodiagnostics, reproductive health, and applied genomics. Second, its discovery and analytical solutions is composed of life science, industrial, environmental, and food applications. Revvity offers products and services ranging from genetic screening and environmental analytical tools to informatics and enterprise software.
| Founded: | 1937 | Country: | United States |
| Employees: | N/A | City: | WALTHAM |
| Market Cap: | 9.9B | IPO Year: | N/A |
| Target Price: | $112.92 | AVG Volume (30 days): | 1.8M |
| Analyst Decision: | Buy | Number of Analysts: | 13 |
| Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
| EPS: | 1.99 | EPS Growth: | -3.35 |
| 52 Week Low/High: | $81.36 - $128.28 | Next Earning Date: | 10-27-2025 |
| Revenue: | $2,813,367,000 | Revenue Growth: | 3.37% |
| Revenue Growth (this year): | 5.37% | Revenue Growth (next year): | 3.07% |
Latest Revvity Inc. News
RVTY Breaking Stock News: Dive into RVTY Ticker-Specific Updates for Smart Investing
StockStory
4 days ago
Option Care Health, DaVita, Revvity, West Pharmaceutical Services, and Bausch + Lomb Shares Skyrocket, What You Need To Know
MT Newswires
a month ago
TD Cowen Adjusts Price Target on Revvity to $120 From $126, Maintains Buy Rating
Business Wire
a month ago
Revvity Showcases Progress with Purpose in 2025 Impact Report
Morningstar Research
a month ago
Analyst Report: Revvity, Inc.
MT Newswires
a month ago
Leerink Partners Adjusts Revvity Price Target to $120 From $110, Maintains Outperform Rating
StockStory
2 months ago
Medpace and Revvity Stocks Trade Down, What You Need To Know
Zacks
2 months ago
RVTY Collaborates With Sanofi for Early Detection of Type 1 Diabetes
StockStory
2 months ago
1 Profitable Stock to Own for Decades and 2 We Turn Down
Compare RVTY vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "RVTY Revvity Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.